To date, more than 200 pathogenic nucleotide variants in the ARSB gene have been identified (most of which are missense), suggesting a high molecular heterogeneity of MPS VI in many populations (http://www.uwcm.ac.uk). This evidence concerns the gene ARSB and mucopolysaccharidosis type 6.